| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director, 10% Owner, Executive Chairman
1 company
Corey S Goodman is Director, 10% Owner at ALXO. Corey S Goodman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.9M at current prices.
Net of sales, the ALXO filings show accumulation of 4,034,713 shares.
Corey S Goodman has 9 Form 4 filings on record from July 2020 to February 2026, all as Director, 10% Owner at ALX Oncology (ALXO), 2020–2026.
The 13 reported transactions were 7 option or other derivative awards, 4 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $21.1M and no sales.
The largest open-market purchase was 850,000 shares of ALXO at an average $19.00 on July 21, 2020, about $16.1M.